methylene blue has been researched along with 2019 Novel Coronavirus Disease in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 31 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arentz, J; von der Heide, HJ | 1 |
| Alemany, A; Amado Simon, R; Ancochea, À; Àngel Rodriguez-Arias, M; Ara, J; Baro, B; Bassat, Q; Blanco, I; Blanco, J; Bonet Papell, G; Bonet, M; Cantoni, J; Capdevila-Jáuregui, M; Clotet, B; Contreras, E; Corbacho-Monné, M; Costes, G; Farré, M; Fernández Rivas, G; Forcada Arcarons, A; Galvan-Femenia, I; Garcia Garcia, V; Grifols, JR; Llopis Roca, F; Malchair, P; Marks, M; Millan, A; Millat-Martinez, P; Mitjà, O; Otero, A; Ouchi, D; Piccolo Ferreira, F; Pradenas, E; Prat, N; Puig, J; Ramírez-Morros, A; Rodríguez Codina, J; Rodriguez Cortez, O; Ruibal Suarez, JC; Ruiz-Comellas, A; San José, A; Torrano-Soler, P; Vidal-Alaball, J; Videla, S; Zarauza Pellejero, A | 1 |
| Sasanka, KSBSK; Thangaraju, P; Yella, SHT; Yella, SST | 1 |
| Acedo, P; Amouzadeh Tabrizi, M | 1 |
| Chen, J; Clark, T; Cui, Y; Lendvay, TS; Xu, J | 1 |
| Harcourt, BH; Kabra, KB; Montgomery, JM; Mores, CN; Scholte, FEM; Spiropoulou, CF; Tritsch, SR | 1 |
| Dams, L; de Jaeger, S; Fries, A; Harcourt, BH; Haubruge, E; Heyne, B; Lendvay, TS; Ludwig-Begall, LF; Razafimahefa, RM; Thiry, E; Wielick, C; Willaert, JF | 1 |
| Gordon, PMK; Heyne, B; Vos, KA | 1 |
| An, X; Chen, Y; Fan, H; Jiang, L; Song, L; Tian, L; Tong, Y; Wang, S; You, Y; Zhu, S | 1 |
| Arbona Castaño, C; Avendaño-Solá, C; Berberana Fernández, M; Bueno Cabrera, JL; Domingo-Morera, JM; Duarte, RF; Flores Ballester, E; García Erce, JA; Guerra Domínguez, L; López Aguilar, JC; Madrigal Sánchez, ME; Maglio, LA; Pérez-Olmeda, M; Ramos-Martínez, A; Romera Martínez, I; Rubio Batllés, M; Sáez Serrano, I; Sola Lapeña, C; Velasco-Iglesias, A; Villegas Da Ros, C | 1 |
| Huh, HJ; Kang, M; Kim, HE; Kim, YS; Park, H; Schuck, A | 1 |
| Aparicio-Alonso, M; Attal, R; Bakkar, A; Henry, M; Radman, M; Schwartz, L | 1 |
| Arastoo, M; Harrington, CR; Hull, C; Mazanetz, MP; Miller, S; Robinson, K; Shiells, H; Storey, JMD; Wischik, CM | 1 |
| Fedorov, V; Kholina, E; Khruschev, S; Kovalenko, I; Meerovich, G; Strakhovskaya, M; Vasyuchenko, E | 1 |
| Dixon, K; Gibbins, S; Moghissi, K | 1 |
| Scigliano, G; Scigliano, GA | 2 |
| Alamdari, AH; Alamdari, DH; Amini, S; Banpour, H; Damsaz, M; Keramati, MR; Koliakos, G; Moghaddam, AB; Yarahmadi, A; Zarmehri, AM | 1 |
| Evora, PRB | 1 |
| Bloom, A; Faisal, H; Gaber, AO | 1 |
| Arakeri, G; Rao Us, V | 1 |
| Wiwanitkit, V | 1 |
| Betsy, J; Prasanth, CS | 1 |
| Campos, L; Mattia, MB; Palma, LF; Ramires, MCCH; Tateno, RY | 1 |
| Bazhenov, AI; Bogdanova, AS; Borovkova, NV; Bulanov, AY; Chirkova, KS; Dolzhikova, IV; Dombrovskiy, EA; Drozdova, NE; Ganchin, VV; Gintsburg, AL; Godkov, MA; Kamalova, AR; Kostin, AI; Ladygina, EA; Logunov, DY; Lundgren, MN; Petrikov, SS; Shcheblyakov, DV; Shustov, VV; Volkov, SE | 1 |
| Bansal, N; Kashav, R; Magoon, R; Singh, A | 1 |
| Cheng, L; Jiang, M; Jin, C; Liu, F; Lu, X; Wu, H; Wu, N; Yao, H; Yu, B; Zhang, J; Zhou, X | 1 |
| Chen, J; Chu, LF; Chu, MC; Chu, S; Clark, T; Conly, JM; Cui, Y; Dams, L; Davies, JM; De Jaeger, S; Evans, D; Faris, P; Gallagher, T; Harcourt, BH; Haubruge, E; Heyne, B; Homdayjanakul, K; Hope, K; Jolois, O; Kabra, KB; Kilinc-Balci, FS; Lamb, MM; Laperre, J; Lemyre, JL; Lendvay, TS; Liao, L; Lin, YC; Lin, YL; Ludwig-Begall, LF; Macia, N; Mackie, CJ; Malott, R; Mayo, M; Molloy-Simard, V; Mores, CN; Nauwynck, H; Page, K; Parker, R; Patel, AN; Price, A; Reader, S; Sahni, J; Scholte, FEM; Simmons, SM; Smit, SJ; Thiry, E; Timm, E; Tritsch, SR; Wagner, T; Wielick, C; Willaert, JF; Zhao, M | 1 |
| Cagno, V; Cerny, A; Cerny, E; Cerny, T; Medaglia, C; Tapparel, C; Zwygart, AC | 1 |
| Arbona, C; Callao, V; Castelló, E; Castro, E; Collado, M; Francés-Gómez, C; Geller, R; Giménez, Á; Larrea, L; Mirabet, V; Navarro, L; Ortiz-de-Salazar, MI; Roig, R; Sánchez-Sendra, B; Vayá, MJ; Vera, B | 1 |
| Alexander, A; Dabholkar, N; Dubey, SK; Gorantla, S; Singhvi, G; Taliyan, R | 1 |
1 review(s) available for methylene blue and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Enzyme Inhibitors; Humans; Methylene Blue; SARS-CoV-2 | 2021 |
2 trial(s) available for methylene blue and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial.
Topics: Adult; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Double-Blind Method; Humans; Immunization, Passive; Methylene Blue; Middle Aged; Outpatients; SARS-CoV-2; Treatment Outcome | 2022 |
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasma.
Topics: COVID-19; COVID-19 Serotherapy; Humans; Immunization, Passive; Methylene Blue; SARS-CoV-2; Treatment Outcome | 2023 |
28 other study(ies) available for methylene blue and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Evaluation of methylene blue based photodynamic inactivation (PDI) against intracellular B-CoV and SARS-CoV2 viruses under different light sources in vitro as a basis for new local treatment strategies in the early phase of a Covid19 infection.
Topics: COVID-19; Humans; Methylene Blue; Photochemotherapy; Photosensitizing Agents; RNA, Viral; SARS-CoV-2 | 2022 |
Does Methylene Blue Satisfy an Option in COVID-19 ARDS.
Topics: COVID-19; Humans; Male; Methylene Blue; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
Highly sensitive aptasensor for the detection of SARS-CoV-2-RBD using aptamer-gated methylene blue@mesoporous silica film/laser engraved graphene electrode.
Topics: Aptamers, Nucleotide; Biosensing Techniques; COVID-19; Electrochemical Techniques; Electrodes; Gold; Graphite; Humans; Lasers; Limit of Detection; Methylene Blue; SARS-CoV-2; Silicon Dioxide | 2022 |
Methylene blue applied to N95 respirators and medical masks for SARS-CoV-2 decontamination: What is the likelihood of inhaling methylene blue?
Topics: COVID-19; Decontamination; Equipment Reuse; Humans; Methylene Blue; N95 Respirators; SARS-CoV-2 | 2022 |
Exploring inactivation of SARS-CoV-2, MERS-CoV, Ebola, Lassa, and Nipah viruses on N95 and KN95 respirator material using photoactivated methylene blue to enable reuse.
Topics: COVID-19; Decontamination; Equipment Reuse; Hemorrhagic Fever, Ebola; Humans; Methylene Blue; Middle East Respiratory Syndrome Coronavirus; N95 Respirators; Nipah Virus; Pandemics; SARS-CoV-2; Ventilators, Mechanical | 2022 |
Of masks and methylene blue-The use of methylene blue photochemical treatment to decontaminate surgical masks contaminated with a tenacious small nonenveloped norovirus.
Topics: Animals; COVID-19; Decontamination; Equipment Reuse; Humans; Masks; Methylene Blue; Mice; Norovirus; SARS-CoV-2 | 2022 |
Methylene blue in combination with sunlight as a low cost and effective disinfection method for coronavirus-contaminated PPE.
Topics: Animals; COVID-19; Disinfection; Methylene Blue; Mice; Personal Protective Equipment; SARS-CoV-2; Sunlight | 2022 |
Antiviral Drugs Screening for Swine Acute Diarrhea Syndrome Coronavirus.
Topics: Alphacoronavirus; Animals; Antiviral Agents; COVID-19; Methylene Blue; Mycophenolic Acid; SARS-CoV-2; Swine | 2022 |
Gold nanostructures modified carbon-based electrode enhanced with methylene blue for point-of-care COVID-19 tests using isothermal amplification.
Topics: COVID-19; DNA; Humans; Methylene Blue; Nanostructures; Nucleic Acid Amplification Techniques; Point-of-Care Systems; Point-of-Care Testing; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity | 2023 |
Toxicity of the spike protein of COVID-19 is a redox shift phenomenon: A novel therapeutic approach.
Topics: COVID-19; Humans; Inflammation; Methylene Blue; Oxidation-Reduction; Spike Glycoprotein, Coronavirus; Thioctic Acid | 2023 |
Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants.
Topics: COVID-19; Heme; Humans; Hypoxia; Iron; Methemoglobin; Methylene Blue; Oxygen; Prospective Studies | 2023 |
Interaction of Methylene Blue with Severe Acute Respiratory Syndrome Coronavirus 2 Envelope Revealed by Molecular Modeling.
Topics: Antiviral Agents; Binding Sites; COVID-19; Humans; Methylene Blue; SARS-CoV-2 | 2023 |
Does PDT have potential in the treatment of COVID 19 patients?
Topics: Administration, Inhalation; Cohort Studies; Coronavirus Infections; COVID-19; Female; Humans; Male; Methylene Blue; Pandemics; Patient Selection; Photochemotherapy; Photosensitizing Agents; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Treatment Outcome; Triazenes | 2020 |
Acute respiratory distress syndrome from Covid-19: A perfect storm from free radicals? Proposal for a new treatment.
Topics: Animals; COVID-19; Diagnosis, Differential; Free Radicals; Humans; Inflammation; Methylene Blue; Models, Theoretical; Reactive Nitrogen Species; Reactive Oxygen Species; Respiratory Distress Syndrome; Shock, Septic; Vascular Resistance | 2020 |
Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial.
Topics: Acetylcysteine; Ascorbic Acid; Clinical Trials, Phase I as Topic; Compassionate Use Trials; Coronavirus Infections; COVID-19; Critical Illness; Female; Humans; Hypoxia; Male; Methylene Blue; Middle Aged; Pandemics; Pneumonia, Viral | 2020 |
COVID-19 should be a methylene blue "promoter".
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Methylene Blue; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.
Topics: Acute Kidney Injury; Aged; Antibodies, Monoclonal, Humanized; Antioxidants; Ascorbic Acid; Betacoronavirus; Coronavirus Infections; Corynebacterium; Corynebacterium Infections; COVID-19; Cytokine Release Syndrome; Enzyme Inhibitors; Erythrocyte Transfusion; Hematinics; Humans; Hydroxocobalamin; Hydroxychloroquine; Hypoxia; Male; Methemoglobinemia; Methylene Blue; Pandemics; Pneumonia, Bacterial; Pneumonia, Viral; Renal Replacement Therapy; Respiratory Insufficiency; SARS-CoV-2; Shock, Septic | 2020 |
Methylene blue as an anti-COVID-19 mouthwash in dental practice.
Topics: COVID-19; Dentistry; Humans; Methylene Blue; Mouthwashes; SARS-CoV-2 | 2021 |
Methylene blue in covid-19.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytokines; Endothelium, Vascular; Humans; Methylene Blue; Models, Biological; Multiple Organ Failure; Pandemics; Reactive Oxygen Species; Respiratory Distress Syndrome; SARS-CoV-2; Treatment Failure | 2021 |
COVID-19 and Methylene Blue.
Topics: COVID-19; Humans; Methylene Blue; SARS-CoV-2 | 2021 |
Can photodynamic therapy be repurposed to treat oral lesions of COVID-19?
Topics: Antiviral Agents; COVID-19; Drug Combinations; Humans; Methylene Blue; Photochemotherapy; Photosensitizing Agents; Porphyrins; SARS-CoV-2 | 2021 |
A combination of phototherapy modalities for extensive lip lesions in a patient with SARS-CoV-2 infection.
Topics: COVID-19; Female; Humans; Lip; Low-Level Light Therapy; Methylene Blue; Middle Aged; Photochemotherapy; Photosensitizing Agents; SARS-CoV-2 | 2021 |
Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma.
Topics: Antibodies, Neutralizing; Blood Safety; Blood-Borne Pathogens; COVID-19; COVID-19 Serotherapy; Furocoumarins; Humans; Immunization, Passive; Methylene Blue; Plasma; Riboflavin; SARS-CoV-2 | 2021 |
Methylene blue: Subduing the post COVID-19 blues!
Topics: COVID-19; Humans; Methylene Blue; SARS-CoV-2 | 2021 |
Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19.
Topics: Animals; Blood Safety; Blood Transfusion; Chlorocebus aethiops; COVID-19; COVID-19 Serotherapy; Humans; Immunization, Passive; Methylene Blue; Plasma; RNA, Viral; SARS-CoV-2; Vero Cells; Virus Inactivation | 2021 |
Addressing personal protective equipment (PPE) decontamination: Methylene blue and light inactivates severe acute respiratory coronavirus virus 2 (SARS-CoV-2) on N95 respirators and medical masks with maintenance of integrity and fit.
Topics: COVID-19; Decontamination; Equipment Reuse; Humans; Masks; Methylene Blue; N95 Respirators; Personal Protective Equipment; SARS-CoV-2; Virus Diseases | 2022 |
Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro.
Topics: Animals; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Humans; Influenza, Human; Methylene Blue; SARS-CoV-2; Ultraviolet Rays; Vero Cells; Virus Inactivation; Virus Replication | 2021 |
Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light.
Topics: Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serotherapy; Humans; Immunization, Passive; Immunoglobulin G; Light; Methylene Blue; SARS-CoV-2 | 2022 |